PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
25-Mar-2020 TRANSPARENT PEER REVIEW COMES TO ROYAL SOCIETY OF CHEMISTRY Royal Society of Chemistry
25-Mar-2020 1 week to go to SMi’s 22nd Annual Superbugs & Superdrugs Conference  SMi Group
23-Mar-2020 Synairgen to start trial of SNG001 in COVID-19 imminently Synairgen plc
23-Mar-2020 Helsinn announces European approval of the IV formulation of AKYNZEO® (fosnetupitant / palonosetron) Helsinn Group
23-Mar-2020 Syncona Limited Business Update Syncona Limited
23-Mar-2020 All patients in the European MOB-015 Phase 3 study have completed their last visit Moberg Pharma AB
23-Mar-2020 Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates BONE THERAPEUTICS
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech
23-Mar-2020 Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy Vaccitech Limited
23-Mar-2020 Immutep’s partner, EOC Pharma, reports completion of recruitment of phase I study of Efti Immutep
23-Mar-2020 INVESTIGATION REVEALS £21 MILLION NHS BILL FOR AVOIDABLE DEFICIENCIES IN HEART FAILURE BMJ journal
23-Mar-2020 ISA Pharma publishes phase 2 study data in major peer-reviewed journal ISA Pharmaceuticals
23-Mar-2020 NDA Group tackles increased regulatory complexity for Medical Device manufacturers through new division NDA Group
23-Mar-2020 Ergomed Announces Provision of Clinical Research Services for COVID-19 Clinical Study Ergomed plc
23-Mar-2020 Britain’s fastest-growing privately-owned pharma companies revealed Alantra
23-Mar-2020 Eureka Therapeutics Completes $45 Million Series E Financing and Enters into Strategic Collaboration with Lyell Immunopharma Eureka Therapeutics
23-Mar-2020 Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa eona Therapeutics
23-Mar-2020 Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine Pfizer
23-Mar-2020 Statement on COVID-19 from the European Cancer Organisation’s Board of Directors: ‘Attention is urgently required to protect cancer patients and preserve Europe’s healthcare professional, scientific and patient societies’ Board of Directors of the European Cancer Organisation
23-Mar-2020 Haselmeier Receives Medical Device Master File Number for D-Flex Product Platform Haselmeier